Level Four Advisory Services’s Teva Pharmaceuticals TEVA Stock Holding History

Level Four Advisory Services’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-12,002	Closed	-$188K	–	534
2019 Q1	$188K	Sell	12,002 -1,985	-14%	-$35K	0.02%	489
2018 Q4	$216K	Sell	13,987 -6,477	-32%	-$133K	0.03%	465
2018 Q3	$441K	Buy	20,464 +105	+0.5%	+$2.44K	0.05%	366
2018 Q2	$495K	Buy	20,359 +12	+0.1%	+$245	0.04%	383
2018 Q1	$348K	Buy	20,347 +1,850	+10%	+$36.1K	0.03%	414
2017 Q4	$351K	Buy	18,497 +3,364	+22%	+$50.6K	0.03%	419
2017 Q3	$266K	Buy	+15,133	New	+$340K	0.02%	442

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Level Four Advisory Services's TEVA Position: Q2 2019 in Review

Level Four Advisory Services sold out of Teva Pharmaceuticals (TEVA) in Q2 2019, closing a stake of 12,002 shares — an estimated $188K sold.

Level Four Advisory Services first reported a position in TEVA in Q3 2017 and held it in 7 quarters. The position peaked at $495K in Q2 2018. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

Level Four Advisory Services reported no remaining Teva Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Level Four Advisory Services sold 12,002 Teva Pharmaceuticals shares in Q2 2019, an estimated $188K.
Level Four Advisory Services first reported a position in Teva Pharmaceuticals in Q3 2017 and held it in 7 quarters.
Level Four Advisory Services's Teva Pharmaceuticals position peaked at $495K in Q2 2018.
452 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2019.

Based on Level Four Advisory Services's 13F filing for Q2 2019, filed 14 Aug 2019.